Blend Labs, Inc. (NYSE:BLND – Get Free Report) insider Brian Kneafsey sold 30,000 shares of Blend Labs stock in a transaction dated Tuesday, December 31st. The stock was sold at an average price of $4.27, for a total value of $128,100.00. Following the sale, the insider now directly owns 896,759 shares of the company’s stock, valued at $3,829,160.93. This trade represents a 3.24 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink.
Brian Kneafsey also recently made the following trade(s):
- On Tuesday, December 17th, Brian Kneafsey sold 30,000 shares of Blend Labs stock. The shares were sold at an average price of $5.05, for a total transaction of $151,500.00.
- On Tuesday, December 10th, Brian Kneafsey sold 30,000 shares of Blend Labs stock. The shares were sold at an average price of $5.12, for a total transaction of $153,600.00.
Blend Labs Stock Down 8.8 %
Blend Labs stock traded down $0.37 during mid-day trading on Thursday, hitting $3.84. The company had a trading volume of 4,899,229 shares, compared to its average volume of 2,411,210. Blend Labs, Inc. has a 1 year low of $2.08 and a 1 year high of $5.53. The business has a fifty day moving average of $4.56 and a 200 day moving average of $3.71. The stock has a market cap of $982.77 million, a price-to-earnings ratio of -11.29 and a beta of 1.33.
Institutional Trading of Blend Labs
Analysts Set New Price Targets
A number of research firms have recently commented on BLND. JMP Securities initiated coverage on shares of Blend Labs in a research note on Wednesday, December 18th. They set an “outperform” rating and a $7.00 target price for the company. The Goldman Sachs Group upped their price target on Blend Labs from $3.40 to $3.90 and gave the company a “buy” rating in a research note on Thursday, November 7th. UBS Group boosted their target price on Blend Labs from $3.00 to $4.00 and gave the company a “neutral” rating in a research report on Wednesday, October 23rd. Keefe, Bruyette & Woods increased their price target on shares of Blend Labs from $3.25 to $3.85 and gave the stock a “market perform” rating in a research report on Thursday, November 7th. Finally, Canaccord Genuity Group reaffirmed a “buy” rating and set a $5.75 target price on shares of Blend Labs in a research note on Friday, December 20th. Two research analysts have rated the stock with a hold rating, six have given a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $5.11.
Check Out Our Latest Stock Analysis on Blend Labs
Blend Labs Company Profile
Blend Labs, Inc engages in the provision of cloud-based software platform solutions for financial services firms in the United States. It operates in two segments, Blend Platform and Title365. The company's Blend Builder Platform offers a suite of products that powers digital-first consumer journeys for mortgages, home equity loans and lines of credit, vehicle loans, personal loans, credit cards, and deposit accounts; and offers mortgage products to facilitate the homeownership journey for consumers comprising close, income verification for mortgage, homeowners' insurance, and realty.
See Also
- Five stocks we like better than Blend Labs
- What is the Australian Securities Exchange (ASX)
- 3 Legacy Tech Companies Reemerging as AI Leaders
- 5 discounted opportunities for dividend growth investors
- Analysts’ Favorite Cybersecurity Stocks: 3 Top Picks
- Transportation Stocks Investing
- Analysts Are Bullish: 3 Tech Giants With Upgraded Price Targets
Receive News & Ratings for Blend Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Blend Labs and related companies with MarketBeat.com's FREE daily email newsletter.